- Abstract
- Core Tip
- Full Article (PDF)
- Full Article (WORD)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (117)
- Timeline of Article Publication Processes (6)
- Authors Evaluation (6)
- Article Quality Tracking (0)
- Reader Comments (1)
- Reference Citation Analysis (System.Threading.Tasks.Task`1[System.Int32])
-
Full Article (HTML) (38) -
Full Article (PDF) (17) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1805)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 25, 2022 (publication date) through Jul 3, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Saravanan UB, Namachivayam M, Jeewon R, Huang JD, Durairajan SSK. Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation. World J Virol 2022; 11(1): 40-56 [PMID: 35117970 DOI: 10.5501/wjv.v11.i1.40] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v11/i1/40.htm |
| Number | Citing Articles |
| 1 |
Shikha Tiwari, Garima Goel, Ashok Kumar. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19. International Reviews of Immunology 2022; : 1 doi: 10.1080/08830185.2022.2089666
|
| 2 |
Peter Buchwald. Developing Small-Molecule Inhibitors of Protein-Protein Interactions Involved in Viral Entry as Potential Antivirals for COVID-19. Frontiers in Drug Discovery 2022; 2 doi: 10.3389/fddsv.2022.898035
|